Daré Bioscience Files Reg FD Corporate Presentation (Oct 1, 2026)

What Happened
Daré Bioscience, Inc. (DARE) filed a Form 8‑K on October 1, 2026 (Item 7.01) to furnish a corporate presentation dated October 1, 2026 (Exhibit 99.1). The company said it will use this presentation in meetings with securities market participants and others starting October 1, 2026, and plans to post a copy on the “Presentations” page of the Investors section of its website. The filing notes that information on the website is not incorporated by reference into the 8‑K.

Key Details

• Filing date: October 1, 2026 (Form 8‑K, Item 7.01).
• Furnished exhibit: Exhibit 99.1 — Daré corporate presentation dated October 1, 2026.
• Use: Presentation to be used in meetings with securities market participants and others commencing October 1, 2026.
• Availability: Company will make the presentation available on its investor website under “Presentations, Events & Webcasts.”

Why It Matters
This is a Regulation FD disclosure: Daré is publicly sharing a standardized presentation it will use with investors and analysts. The 8‑K itself does not report earnings, revenue, management changes, or other financial results—only that the presentation has been furnished. Investors who want the latest company presentation or any material updates should review the posted exhibit on Daré’s investor website.